Aptevo Therapeutics (APVO)
(Delayed Data from NSDQ)
$0.35 USD
-0.02 (-5.00%)
Updated Aug 28, 2024 03:58 PM ET
After-Market: $0.34 -0.01 (-3.30%) 7:36 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Aptevo Therapeutics Inc. [APVO]
Reports for Purchase
Showing records 81 - 98 ( 98 total )
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
We are transferring coverage to Jonathan Aschoff, Ph.D., with a Buy rating and a $3 target price
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Transferring Coverage Update - Biotechnology Sector
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Transfer of Coverage; Maintain Buy and $12PT
Provider: Roth Capital Partners, Inc.
Analyst: ISAACSON J
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptevo Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Out With the Old, in With the New; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
Healthcare - ORD-ARN-JFK: Crossing Our Onco Radar
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
Dissecting Recent Progress and Value; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptevo Therapeutics Inc.
Industry: Unclassified
An Eclectic Pipeline Trading at Cash; Initiating with Buy and $12 PT
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J